TOP CLASS HEALTHCARE, FI
Cartera
Este fondo se corresponde con los siguientes códigos ISIN: ES0179362001
| Patrimonio | 5.195.593€ |
|---|---|
| Partícipes | 245 |
| Patrimonio por partícipe | 21.206,50€ |
Cartera del fondo a 2018-06-30
El fondo invierte en 66 activos diferentes:
| Activo | ISIN | Porcentaje |
|---|---|---|
| ROCHE HOLDG | CH0012032048 | 4,70% |
| MERCK & CO. | US58933Y1055 | 4,48% |
| JOHNSON & JOHNSON S | US4781601046 | 4,48% |
| MEDTRONIC PLC | IE00BTN1Y115 | 3,61% |
| HCA HOLDINGS INC | US40412C1018 | 3,25% |
| GILEAD SCIENCES | US3755581036 | 2,99% |
| PFIZER INC. | US7170811035 | 2,76% |
| AMGEN INC. | US0311621009 | 2,73% |
| ISHARES NASDAQ BIOTECH INDX | US4642875565 | 2,55% |
| ANTHEM INC | US0367521038 | 2,51% |
| CELGENE CORP | US1510201049 | 2,35% |
| REGENERON PHARMACEUTICALS | US75886F1075 | 2,33% |
| STRYKER CORP | US8636671013 | 2,32% |
| BRISTOL-MYERS | US1101221083 | 2,16% |
| CIGNA CORP | US1255091092 | 2,15% |
| RECKITT BENCKISER GROUP PLC (EUR) | GB00B24CGK77 | 2,09% |
| COTY INC -CL A | US2220702037 | 2,08% |
| SANOFI | FR0000120578 | 1,95% |
| NOVARTIS AG REG.SHS. | CH0012005267 | 1,93% |
| MYLAN NV -- NASDAQ | NL0011031208 | 1,91% |
| JAZZ PHARMACEUTICALS PLC | IE00B4Q5ZN47 | 1,82% |
| ABBVIE INC | US00287Y1091 | 1,76% |
| CHINA BIOLOGIC PRODUCTS INC | KYG215151047 | 1,68% |
| MERCK KGAA | DE0006599905 | 1,65% |
| UNITEDHEALTH GROUP | US91324P1021 | 1,55% |
| THERMO FISHER SCIENTIFIC INC | US8835561023 | 1,53% |
| ZIMMER BIOMET HOLDINGS INC | US98956P1021 | 1,53% |
| MCKESSON CORP | US58155Q1031 | 1,41% |
| HORIZON PHARMA PLC | IE00BQPVQZ61 | 1,40% |
| ALLSCRIPTS HEALTHCARE SOLUTIONS | US01988P1084 | 1,39% |
| DANAHER CORP | US2358511028 | 1,35% |
| LIFEPOINT HOSPITALS | US53219L1098 | 1,34% |
| ALEXION PHARMACEUTICALS INC | US0153511094 | 1,31% |
| RAMSAY HEALTH CARE LTD | AU000000RHC8 | 1,26% |
| BIOGEN IDEC INC | US09062X1037 | 1,23% |
| ELI LILLY & CO | US5324571083 | 1,08% |
| USANA HEALTH SCIENCES INC | US90328M1071 | 0,97% |
| BOSTON SCIENTIFIC CORP | US1011371077 | 0,97% |
| ARENA PHARMACEUTICALS INC | US0400476075 | 0,92% |
| ARRAY BIOPHARMA INC | US04269X1054 | 0,89% |
| NUVASIVE INC | US6707041058 | 0,83% |
| INTERCEPT PHARMACEUTICALS IN | US45845P1084 | 0,80% |
| CENTENE CORPORATION | US15135B1017 | 0,78% |
| GRIFOLS SA-ADR | US3984384087 | 0,77% |
| COLGATE PALMOLIVE | US1941621039 | 0,68% |
| INTRA-CELLULAR THERAPIES | US46116X1019 | 0,67% |
| ESTIA HEALTH LTD | AU000000EHE2 | 0,67% |
| PRIMARY HEALTH CARE LTD | AU000000PRY5 | 0,65% |
| WALGREEN BOOTS ALLIANCE | US9314271084 | 0,63% |
| IRONWOOD PHARMACEUTICALS INC | US46333X1081 | 0,61% |
| ALLERGAN PLC -- NYSE | IE00BY9D5467 | 0,60% |
| ANI PHARMACEUTICALS INC | US00182C1036 | 0,56% |
| SERES THERAPEUTICS | US81750R1023 | 0,54% |
| MAYNE PHARMA GROUP LTD | AU000000MYX0 | 0,54% |
| INTELLIA THERAPEUTICS | US45826J1051 | 0,52% |
| NEWLINK GENETICS CORP | US6515111077 | 0,50% |
| BLUEBIRD BIO | US09609G1004 | 0,50% |
| ACCELERATE DIAGNOSTICS INC | US00430H1023 | 0,47% |
| BELLICUM PHARMACEUTICALS INC | US0794811077 | 0,47% |
| REVANCE THERAPEUTICS INC | US7613301099 | 0,46% |
| ACADIA PHARMACEUTICALS INC | US0042251084 | 0,45% |
| COHERUS BIOSCIENCES INC | US19249H1032 | 0,44% |
| ACHAOGEN INC | US0044491043 | 0,42% |
| CELLDEX THERAPEUTICS INC | US15117B1035 | 0,32% |
| TESARO INC | US8815691071 | 0,28% |
| PROTAGONIST THERAPEUTICS | US74366E1029 | 0,23% |
Tenga en cuenta que el informe de cartera del fondo hace referencia a cierre del mercado del día y en ningún caso los activos que aparecen aquí están ponderados durante las sesiones del trimestre anterior
TOP CLASS HEALTHCARE, FI
Fondo de inversión armonizado gestionado por RENTA 4 GESTORA, S.G.I.I.C., S.A.
5,2M
patrimonio
245
partícipes
6, en una escala de 1 al 7
perfil de riesgo